health_en

Abcam completes $340m strategic acquisition and expands kit capacity and capability

– Completing $340m strategic acquisition of BioVision – Expanding facilities in Eugene, further growing kits and assays portfolio – Supporting the growing demand of the sector and accelerating execution of strategic plan Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the successful completion of its acquisition of BioVision and the expansion of its immunoassay […]

thaipr.net

27 ต.ค. 64

Medigen’s MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines

Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World Health Organisation (WHO) Solidarity Trial Vaccines (STv). Following the review of around 20 candidate vaccines by the external advisory group, MVC’s vaccine was selected as one of two to be included in the global […]

thaipr.net

27 ต.ค. 64

Educating children about good hygiene is key to helping reduce future health threats

The COVID-19 pandemic has heightened awareness globally of the role that hygiene measures like handwashing can play in infection prevention. Handwashing at high-risk moments is a proven and cost-effective way of reducing common infections by up to 50%. Research by University College London shows a decline in handwashing compliance, with 44% of adults always washing their […]

thaipr.net

26 ต.ค. 64

NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes

International collaboration publishes first of several evidence-based expert consensus guidelines with latest cancer treatment recommendations, beginning with cervical cancer. The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines® for Cervical Cancer: Poland Edition. This is the organization’s most-recent collaboration to…

thaipr.net

25 ต.ค. 64

Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer

– Study met both primary endpoints in patients with ER+/HER2- advanced or mBC – Elacestrant becomes the first oral SERD with positive topline results in pivotal study as a monotherapy versus SoC for the treatment of ER+/HER2- advanced or mBC – Elacestrant extended PFS in the overall population and the ESR1 mutation subgroup – Plans for […]

thaipr.net

21 ต.ค. 64

EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization

EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, and Intouch Group®, a full-service global agency network serving the pharmaceutical industry, today announced that they signed an agreement to incorporate Intouch’s industry-leading creative and media services, enterprise solutions and data analytics into EVERSANA’s fully integrated commercialization services platform. Together, the…

thaipr.net

21 ต.ค. 64
1 … 92 93 94 95 96 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.